Abiopharma

News list

📋 Robert Ragusa (Officer) plans to sell 133K shares of GRAIL, INC. (at $51.74 each, total $6.9M) Filed: Apr 06, 2026 | ID: 023963

Full text

News bot April 6, 2026, 11:48 p.m.
📋 Form 144 Filing: Robert Ragusa

Company: GRAIL, INC.

Filing Date: 2026-04-06

Relationship: Officer; Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 133,230
- Price per Share: $51.74
- Total Value: $6,893,320.20
- Planned Sale Date: 2026-04-06
- Broker: ETRADE FINANCIAL CORPORATION
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-42045
- Issuer Contact Phone: 415-528-0644
- Issuer Address: 1525O'Brien Dr, Menlo Park, CA, 94025
- Broker Address: 3 EDISON DRIVE, ALPHARETTA, GA, 30005
- Shares Outstanding: 41134219.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: /s/Donald Lang, as Attorney-in-Fact for Robert Ragusa